throbber
Page 1 of 6
`
`Actress Marisa Tomei Partners with
`Allergan to Raise Awareness of
`Chronic Dry Eye
`- Famed actress launches charitable partnership with Guide Dogs for the
`Blind and discusses her experience and treatment with RESTASIS®
`(cyclosporine ophthalmic emulsion) 0.05% -
`
`NEWS PROVIDED BY
`Allergan plc
`○
`20 Jul, 2016, 07:59 ET
`
`DUBLIN, July 20, 2016 /PRNewswire/ -- Actress Marisa Tomei today announced that
`she is partnering with Allergan plc (NYSE: AGN) to raise awareness and educate
`consumers about Chronic Dry Eye disease (CDE). Tomei was recently diagnosed
`with a type of CDE and hopes that by sharing her story she can help others learn
`more about the disease and encourage them to speak with their eye doctors.
`
`Logo - http://photos.prnewswire.com/prnh/20150612/222796LOGO
`
`http://www.prnewswire.com/news-releases/actress-marisa-tomei-partners-with-allergan-to-raise-awareness-of-chronic-dry-eye-300301221.html
`
`MYLAN - EXHIBIT 1111
`Mylan Pharmaceuticals Inc. et al. v. Allergan, Inc.
`IPR2016-01127, -01128, -01129, -01130, -01131, & -01132
`
`

`

`Page 2 of 6
`
`"At first I didn't give my dry eyes much thought, but after a while they began
`bothering me throughout the day, causing me to take frequent breaks from
`filming to reapply over the counter eye drops," said Marisa. "After examining my
`eyes, my eye doctor told me I have a type of Chronic Dry Eye disease. I was relieved
`to know there was a reason why my eyes were feeling so dry, and I now use
`RESTASIS to help my eyes make more of their own tears."

`
`RESTASIS (cyclosporine ophthalmic emulsion) 0.05% is the only prescription

`available to help people whose tear production is suppressed due to ocular
`inflammation make more of their own real tears. RESTASIS did not increase tear

`production in patients using anti-inflammatory eye drops or tear duct plugs.
`
`Approximately 31 million Americans suffer from dry eye. One type of CDE is caused
`by decrease tear production due to ocular inflammation. Healthy eyes need tears.
`Without enough tears, the film protecting the eye can break down, creating dry
`spots on the surface of the eye.
`
`"Like Marisa, many patients struggle for years with their dry eye symptoms before
`discussing them with their eye doctors," said Christopher E. Starr, M.D., Associate
`Professor of Ophthalmology, Director of Laser Vision Correction Surgery, and
`Director of the Fellowship Program in Cornea, Cataract & Refractive Surgery at
`Weill Cornell Medicine, New York-Presbyterian Hospital. "Chronic Dry Eye is a
`progressive disease, and if you find that you're experiencing dry eyes and you're
`using artificial tears more often, it's important to see your eye doctor to discuss
`treatment options."
`
`As part of this partnership, Marisa is thrilled to announce that Allergan will be
`donating $1 for every Dry Eye Quiz taken on RESTASIS.com to Guide Dogs for the
`Blind, a charitable organization that empowers the lives of the visually impaired by
`fostering exceptional partnerships between people, dogs and communities*.
`
`http://www.prnewswire.com/news-releases/actress-marisa-tomei-partners-with-allergan-to-raise-awareness-of-chronic-dry-eye-300301221.html
`
`

`

`Page 3 of 6
`
`Allergan has a rich heritage in innovative eye treatments and has been an expert in
`eye care for the past 66 years, and this donation reflects Allergan's ongoing
`commitment and dedication supporting eye health.
`
`"Guide Dogs for the Blind is honored to partner with Allergan and we truly
`appreciate their support for our mission. Guide Dogs for the Blind is an industry-
`leading guide dog school, all of our services are provided free of charge and we
`receive no government funding. The support of community partners such as
`Allergan makes a positive difference and enhances our efforts to serve and
`empower the blind and visually-impaired," said Christine Benninger, President and
`CEO of Guide Dogs for the Blind.
`
`Learn more about Marisa's story and take the Dry Eye Quiz at www.res-
`tasis.com/Guide-Dogs-for-the-Blind.
`
`* For every Dry Eye quiz taken on RESTASIS.com from July 25, 2016 through
`December 31, 2016, Allergan will donate $1 to Guide Dogs for the Blind, with a
`minimum donation of $50,000 and a maximum donation of $100,000.
`
`RESTASIS® Important Information
`
`Approved Use
`
`RESTASIS Ophthalmic Emulsion helps increase your eyes' natural ability to

`produce tears, which may be reduced by inflammation due to Chronic Dry Eye.
`RESTASIS did not increase tear production in patients using anti-inflammatory

`eye drops or tear duct plugs.
`
`Important Safety Information
`
`http://www.prnewswire.com/news-releases/actress-marisa-tomei-partners-with-allergan-to-raise-awareness-of-chronic-dry-eye-300301221.html
`
`

`

`Page 4 of 6
`
`Do not use RESTASIS Ophthalmic Emulsion if you are allergic to any of the

`ingredients. To help avoid eye injury and contamination, do not touch the vial tip to
`your eye or other surfaces. RESTASIS® should not be used while wearing contact
`lenses. If contact lenses are worn, they should be removed prior to use of
`RESTASIS and may be reinserted after 15 minutes.

`
`The most common side effect is a temporary burning sensation. Other side effects
`include eye redness, discharge, watery eyes, eye pain, foreign body sensation,
`itching, stinging, and blurred vision.
`
`You are encouraged to report negative side effects of prescription drugs to the
`FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
`
`Please see full Prescribing Information for Restasis
`
`About Guide Dogs for the Blind
`
`Guide Dogs for the Blind is more than an industry-leading guide dog school; we are
`a passionate community that serves the visually impaired. With exceptional client
`services and a robust network of trainers, puppy raisers, donors, and volunteers, we
`prepare highly qualified guide dogs to serve and empower individuals who are
`blind or have low vision. All of our services are provided free of charge; we receive
`no government funding. GDB is headquartered in San Rafael, California, with a
`second campus in Boring, Oregon. More than 14,000 teams have graduated since
`our founding in 1942, and there are approximately 2,200 active teams in the field.
`For more information, please visit www.guidedogs.com.
`
`About Allergan
`
`http://www.prnewswire.com/news-releases/actress-marisa-tomei-partners-with-allergan-to-raise-awareness-of-chronic-dry-eye-300301221.html
`
`

`

`Page 5 of 6
`
`Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a unique, global
`pharmaceutical company and a leader in a new industry model – Growth Pharma. 
`Allergan is focused on developing, manufacturing and commercializing innovative
`branded pharmaceuticals, high-quality generic and over-the-counter medicines
`and biologic products for patients around the world.
`
`Allergan markets a portfolio of best-in-class products that provide valuable
`treatments for the central nervous system, eye care, medical aesthetics,
`gastroenterology, women's health, urology, cardiovascular and anti-infective
`therapeutic categories, and operates the world's third-largest global generics
`business, providing patients around the globe with increased access to affordable,
`high-quality medicines. Allergan is an industry leader in research and
`development, with one of the broadest development pipelines in the
`pharmaceutical industry and a leading position in the submission of generic
`product applications globally.
`
`With commercial operations in approximately 100 countries, Allergan is
`committed to working with physicians, healthcare providers and patients to deliver
`innovative and meaningful treatments that help people around the world live
`longer, healthier lives.
`
`For more information, visit Allergan's website at www.allergan.com.
`
`Forward-Looking Statement
`
`Statements contained in this press release that refer to future events or other non-
`historical facts are forward-looking statements that reflect Allergan's current
`perspective of existing trends and information as of the date of this release. Except
`as expressly required by law, Allergan disclaims any intent or obligation to update
`these forward-looking statements. Actual results may differ materially from
`Allergan's current expectations depending upon a number of factors affecting
`
`http://www.prnewswire.com/news-releases/actress-marisa-tomei-partners-with-allergan-to-raise-awareness-of-chronic-dry-eye-300301221.html
`
`

`

`Page 6 of 6
`
`Allergan's business. These factors include, among others, the difficulty of predicting
`the timing or outcome of FDA approvals or actions, if any; the impact of
`competitive products and pricing; market acceptance of and continued demand
`for Allergan's products; difficulties or delays in manufacturing; and other risks and
`uncertainties detailed in Allergan's periodic public filings with the Securities and
`Exchange Commission, including but not limited to Allergan's Annual Report on
`Form 10-K for the year ended December 31, 2015 and Quarterly Report on Form
`10-Q for the quarter ended March 31, 2016 (such periodic public filings having been
`filed under the "Actavis plc" name). Except as expressly required by law, Allergan
`disclaims any intent or obligation to update these forward-looking statements.
`
`CONTACTS:     
`
`Investors:
`Lisa DeFrancesco
`(862) 261-7152
`
`Media:
`Mark Marmur
`(973) 906-1526
`
`Frances DeSena
`(201) 427-8762
`
`SOURCE Allergan plc
`
`Related Links
`http://www.allergan.com
`
`http://www.prnewswire.com/news-releases/actress-marisa-tomei-partners-with-allergan-to-raise-awareness-of-chronic-dry-eye-300301221.html
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket